PTC Therapeutics’ Mark Boulding, exec VP, sells $432,117 in stock

Markets Investing.com By Investing.com 08 Jul 2026 21:24 1 min read

PTC Therapeutics’ Mark Boulding, exec VP, sells $432,117 in stock

PTC Therapeutics’ Mark Boulding, exec VP, sells $432,117 in stock

PTC Therapeutics’ Mark Boulding, exec VP, sells $432,117 in stock

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.